EG 427 PINPOINT GENE THERAPY
LIVE

Serial Number

90792354

Owner

EG427

Attorney

Pina Campagna

Filing Date

Jun 24, 2021

Add to watchlist:

No watchlists yet
View on USPTO

EG 427 PINPOINT GENE THERAPY Trademark

Serial Number: 90792354 • Registration: 6933394

EG 427 PINPOINT GENE THERAPY is a trademark filed by EG427 on June 24, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

EG427 (2 trademarks)

PARIS 75014 , FR

Entity Type: 34

GENELPIS

11B Rue Saint-Dominique
Paris 75007 , FR

Entity Type: 99

Trademark Details

Filing Date

June 24, 2021

Registration Date

December 27, 2022

Published for Opposition

October 11, 2022

Goods & Services

Pharmaceutical preparations for use as treatments of neurological pathologies; biological tissue cultures for medical purposes; albuminous preparations for medical purposes; chemical preparations for use as treatments of neurological pathologies; Chemical and biological reagents for medical, pharmaceutical or veterinary purposes; reagents and culture media for in vitro medical, pharmaceutical or veterinary diagnosis; Pharmaceutical preparations for human use for the treatment of neurological pathologies; Bacterial, bacteriological, biological and chemical preparations for medical and therapeutic purposes, namely, for treatment of neurological pathologies

Chemical and biochemical preparations for scientific and research purposes; reagents for scientific and research purposes; chemical preparations and chemical reagents for industrial, agri-food, cosmetic, pharmaceutical and environmental purposes, other than for medical or veterinary use; Stem cells for research purposes; Bacterial, bacteriological, biological and chemical preparations for scientific purposes other than for medical or veterinary use

Surgical apparatus and instruments for medical or veterinary use; therapeutic and assistive devices to diagnose or administer treatments for cardiovascular, digestive, endocrine, genitourinary, genetic, hematological, immune, infectious, neurological, oncologic, respiratory, sight, hearing, pulmonary and skin diseases, designed for people with disabilities; In vitro diagnostic apparatus and instruments for medical, pharmaceutical or veterinary use in the field of gene therapy for diagnosis of cardiovascular, digestive, endocrine, genitourinary, genetic, hematological, immune, infectious, neurological, oncologic, respiratory, and skin diseases

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 27, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 27, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 11, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 11, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 21, 2022 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Sep 7, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 2, 2022 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 26, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 23, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 22, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 22, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 25, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 25, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 25, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 16, 2022 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 4, 2022 ASGN
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 9, 2021 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2021 NWOS
NEW APPLICATION ENTERED
Jun 28, 2021 NWAP